Cart
sales@molnova.com
GSK3-IN-2
CAS No. 380450-97-5
GSK3-IN-2( —— )
Catalog No. M36509 CAS No. 380450-97-5
GSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 109 | Get Quote |
|
| 5MG | 168 | Get Quote |
|
| 10MG | 278 | Get Quote |
|
| 25MG | 542 | Get Quote |
|
| 50MG | 772 | Get Quote |
|
| 100MG | 1044 | Get Quote |
|
| 500MG | 2097 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK3-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK3-IN-2 is a potent GSK3 inhibitor for the treatment of diabetes and neurodegenerative diseases.
-
DescriptionGSK3-IN-2 (compound 8) is a potent GSK3 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number380450-97-5
-
Formula Weight313.42
-
Molecular FormulaC17H19N3OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C=2C(C3=C(NC2CC(C)(C)C1)NN=C3C)C=4C=CSC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Edward Scolnick, et al. Uses of paralog-selective inhibitors of gsk3 kinases. US20160375006A1.
molnova catalog
related products
-
GSK-3 inhibitor 4
GSK-3 inhibitor 4 is an orally active and brain-permeable compound that acts as a triple inhibitor of GSK-3, CDK2, and CDK5, with IC50 values of 0.56 nM (GSK-3β), 0.45 nM (GSK-3α), 0.47 μM (CDK2), and 0.68 μM (CDK5).
-
GSK-3β inhibitor 14
GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) is a weak GSK-3β inhibitor, IC50﹥ 100μM.
-
AZD1080
AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with Ki of 6.9 nM and 31 nM, respectively.
